<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03832790</url>
  </required_header>
  <id_info>
    <org_study_id>19-0186</org_study_id>
    <nct_id>NCT03832790</nct_id>
  </id_info>
  <brief_title>Sleep, Glycemic Control, and Insulin Resistance in Adolescents With Type 1 Diabetes</brief_title>
  <acronym>SunDIAL</acronym>
  <official_title>Sleep, Glycemic Control, and Insulin Resistance in Adolescents With Type 1 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Juvenile Diabetes Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Colorado Clinical &amp; Translational Sciences Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite advancements in care, most adolescents with T1D have higher BMI and significantly
      higher HbA1c than recommended and are markedly IR, placing them at increased risk for CVD1,2.
      Thus, alternative approaches to improve and maintain glycemic control, IR, and BMI for
      adolescents with T1D are urgently needed. This proposal moves beyond the current insulin and
      carbohydrate counting-focused lifestyle change paradigm to focus on sleep and circadian
      misalignment, which will allow for identification of new mechanisms that can be directly
      translated into future intervention and prevention trials. The goal of the current study is
      to utilize multiple objective measures of sleep duration, timing (actigraphy), and circadian
      rhythm (melatonin) in adolescents with type 1 diabetes (T1D; N = 40) and examine
      relationships with glycemic control, IR, vascular health, and BMI. Further, qualitative
      methodology will be used to identify barriers and facilitators to healthy sleep in
      adolescents with T1D.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 4, 2019</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>HbA1c</measure>
    <time_frame>at 60 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>glycemic variability (CGM glucose SD)</measure>
    <time_frame>at 2 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>insulin sensitivity from hyperinsulinemic euglycemic clamp</measure>
    <time_frame>at study entry (baseline)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>BMI</measure>
    <time_frame>at study entry (baseline)</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Type1diabetes</condition>
  <condition>Adolescent Behavior</condition>
  <condition>Sleep</condition>
  <arm_group>
    <arm_group_label>adolescents with type 1 diabetes</arm_group_label>
    <description>Adolescents ages 14-19 with type 1 diabetes</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>observation</intervention_name>
    <description>observation</description>
    <arm_group_label>adolescents with type 1 diabetes</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adolescents with type 1 diabetes
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  attending high school

          -  diagnosis of type 1 diabetes &gt;1 year

        Exclusion Criteria:

          -  current diagnosis of a sleep disorder (e.g., insomnia, OSA) or abnormal scores on
             sleep disorders screening measures

          -  regular use of medications affecting sleep (e.g., stimulants, atypical antipsychotics,
             melatonin, other sleep aids)

          -  HbA1c â‰¥11 or &gt;14% for the previous 2+ measurements

          -  IQ&lt;70 or severe mental illness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>19 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>University of Colorado Anschutz Medical Campus/Children's Hospital Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karissa Valente</last_name>
      <phone>720-777-8486</phone>
      <email>karissa.valente@childrenscolorado.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>February 4, 2019</study_first_submitted>
  <study_first_submitted_qc>February 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 6, 2019</study_first_posted>
  <last_update_submitted>January 8, 2020</last_update_submitted>
  <last_update_submitted_qc>January 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

